The present invention relates to novel Silyl-Containing Heterocyclic Compounds of Formula (I): and pharmaceutically acceptable salts thereof, wherein A, B, C, D, E, F and L are as defined herein. The present invention also relates to compositions comprising at least one Silyl-Containing Heterocyclic Compound, and methods of using the Silyl-Containing Heterocyclic Compounds for treating or preventing HCV infection in a patient.
本发明涉及新的公式(I)中的含
硅杂环化合物以及其药学上可接受的盐,其中A,B,C,D,E,F和L的定义如本文所述。本发明还涉及包含至少一种含
硅杂环化合物的组合物,以及使用含
硅杂环化合物治疗或预防患者HCV感染的方法。